Cigna Group (NYSE:CI) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Cigna Group (NYSE:CI) from a hold rating to a buy rating in a research note published on Saturday,Wall Street Zen reports.

Several other research analysts also recently weighed in on the company. Sanford C. Bernstein boosted their target price on Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Mizuho increased their price target on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their price target for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Cantor Fitzgerald boosted their price target on Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a research note on Friday, May 1st. Finally, Piper Sandler cut their price objective on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Fifteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $339.45.

Cigna Group Price Performance

Shares of CI opened at $276.22 on Friday. The company has a market cap of $72.99 billion, a price-to-earnings ratio of 11.43, a price-to-earnings-growth ratio of 0.96 and a beta of 0.29. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The company has a 50 day moving average of $283.40 and a two-hundred day moving average of $281.22.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same period in the previous year, the company earned $7.20 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, analysts predict that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s payout ratio is currently 25.82%.

Insider Activity

In other news, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares in the company, valued at $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 23,012 shares of company stock worth $6,386,550. Company insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

Hedge funds and other institutional investors have recently bought and sold shares of the business. Wilkerson Advisory Group LLC purchased a new stake in shares of Cigna Group in the 4th quarter valued at $25,000. Osbon Capital Management LLC purchased a new position in shares of Cigna Group during the second quarter worth $26,000. Johnson Financial Group Inc. acquired a new position in Cigna Group during the second quarter valued at $29,000. Kemnay Advisory Services Inc. acquired a new position in Cigna Group during the fourth quarter valued at $29,000. Finally, Prosperity Bancshares Inc purchased a new stake in Cigna Group in the fourth quarter valued at $29,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.